ArticleInternational ophthalmology2025
Multimodal imaging predictors of recurrence after photodynamic therapy in chronic central serous chorioretinopathy.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the correlation between spectral-domain optical coherence tomography (SD-OCT), fundus fluorescein angiography (FFA), and indocyanine green angiography (ICGA) findings and recurrence following photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (cCSC).
methodsWe retrospectively reviewed medical records of 68 eyes from 68 patients diagnosed with cCSC and treated with PDT. Demographic data, duration of symptoms before treatment, baseline best-corrected visual acuity (BCVA), and multimodal imaging features (SD-OCT, FFA, ICGA) were analyzed. Patients were followed up to 24 months post-PDT for recurrence.
resultsThe mean age was 48.1 ± 10.4 years; 76.5% were male. Recurrence was observed in 19 patients (27.9%). Longer symptom duration before PDT (20.9 vs 13.3 months, p = 0.001), presence of non-shallow PED on SD-OCT (68.4% vs 38.8%, p = 0.02), and RPE changes on fundoscopy (94.7% vs 71.4%, p = 0.03) were significantly associated with recurrence. No significant correlation was found with FFA or ICGA findings.
conclusionLonger symptom duration and certain SD-OCT and fundus features may predict recurrence after PDT in cCSC. Recognizing these predictors could help guide earlier treatment decisions.
Indexed as
Identifiers
41369849What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.